Scientists have identified the Aurora A gene — which is vital for tumor growth and known to be expressed at higher-than-normal levels in many cancers — as a target for potential therapies for rhabdoid tumors, aggressive childhood cancers that usually strike children under three years old and affect the brain or kidneys. The disease is extremely rare and is particularly difficult to treat and almost always fatal.